1
/
of
1
Siemens
General Chemistry Reagent Atellica CH Fructosamine For Atellica CH Analyzer 400 Tests
PRODUCT HIGHLIGHTS
- Measurement of fructosamine is representative of blood glucose levels over the preceding 2–3 weeks, and is useful for monitoring diabetic patients
- CH Fructosamine (Fruc) assay is for in vitro diagnostic use in the quantitative measurement of glycated protein (fructosamine) in human serum and plasma (lithium heparin, potassium EDTA) using the Atellica® CH Analyze
- Delivers consistent, high-precision results with streamlined workflow integration
- Intended for the quantitative determination of fructosamine levels in human serum or plasma
Fast Delivery
Auto Delivery , Free Shipping For $100 Above Products
Item | Description | Quantity | Price |
---|---|---|---|
11097637
|
REAGENT, CHEMISTRY ATELLICA FRUC (2X200TESTS) D/S Ships directly from the manufacturer. Additional shipping charges may apply.This Item is non-returnable & non-refundable |
1 Each |
List Price:$2,067.99 Price:$2,001.99 You save $66.00 Add To Cart
|

Description
Fructosamine reagent designed for use with the Atellica CH Analyzer, providing accurate and reliable measurement of glycated serum proteins for effective diabetes monitoring.
Product Features
-
Intended for the quantitative determination of fructosamine levels in human serum or plasma
-
Supports diabetes management by reflecting average blood glucose over 2–3 weeks
-
Optimized for compatibility with the Atellica CH Analyzer
-
Delivers consistent, high-precision results with streamlined workflow integration
-
Suitable for clinical laboratories performing routine and specialized chemistry testing
Specifications
Specification | Details |
---|---|
Manufacturer # | 11097637 |
Manufacturer | Siemens Medical |
Country of Origin | — |
Application | General Chemistry Reagent |
For Use With | Atellica CH Analyzer |
Form | — |
Number of Tests | 400 Tests |
Specialty | General Chemistry |
Storage Requirements | — |
Test Category | Diabetes |
Test Name | Fructosamine |
UNSPSC Code | — |